Topics

Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion

2018-04-03 05:14:11 | BioPortfolio

Summary

This study evaluates dextromethorphan as a non-opioid adjunctive medication for pain control during medication abortion. This is double-blinded, four-arm randomized controlled trial enrolling 156 women over a period of 9-12 months: Receiving narcotics+dextromethorphan, narcotics and placebo (microcrystalline cellulose), no narcotics and dextromethorphan and no narcotics and placebo (microcrystalline cellulose).

Description

Medication abortion using mifepristone and misoprostol is common, accounting for nearly one-third of abortions in the United States in 2014. Although women generally tolerate medical abortion well, pain and bleeding are common and expected side effects. Up to a quarter of women rate their pain as severe during their procedure. Pain management for medical abortion is challenging given that the most acute pain occurs at home rather than under the supervision of medical professionals. Currently there is insufficient evidence to recommend an optimal regimen for pain control in medication abortion and there are concerns surrounding narcotic prescribing and the opiate abuse epidemic. This is a four-arm, prospective, double-blind, randomized controlled trial comparing dextromethorphan administration in conjunction with the current standard regimen (NSAIDs and narcotic medication by request- commonly oxycodone or codeine) to the standard regimen alone. Pain will be evaluated by analgesia usage and self-reported pain scores. Investigators will also investigate factors influencing pain and subjective components of the patient narrative. Ideally, a non-opioid adjunct to NSAIDs or narcotics could be used to control pain and significantly curtail or avoid opioid use. Investigators seek to test the efficacy and safety of dextromethorphan as a non-narcotic analgesic for medication abortion.

Study Design

Conditions

Abortion in First Trimester

Intervention

Dextromethorphan Hydrobromide, Avicel PH101 (Microcrystalline Cellulose NF) for Compounding, Oxycodone

Status

Not yet recruiting

Source

University of Pittsburgh

Results (where available)

View Results

Links

Published on BioPortfolio: 2018-04-03T05:14:11-0400

Clinical Trials [350 Associated Clinical Trials listed on BioPortfolio]

Efficacy Study of Dextromethorphan to Treat Rheumatoid Arthritis

Rheumatoid arthritis were randomized to a 6-month treatment of oral dextromethorphan hydrobromide or placebo as an add-on therapy to traditional disease-modifying anti-rheumatic drugs (DMA...

Comparison of Psyllium and Microcrystalline Cellulose on Glycemic Measures in Subjects With Impaired Fasting Glucose

The Purpose of this study is to compare the effects of 2 types of dietary fiber, psyllium and microcrystalline cellulose (MCC), on glycemic measures in subjects with impaired fasting gluco...

A Double-Blind Placebo-Controlled Trial of Dextromethorphan for Treatment of Major Depressive Disorder

A proof-of-concept study to determine the antidepressant potential of Dextromethorphan for treating depression associated with Major Depressive Disorder in inpatients.

Dextromethorphan in Treating Patients With Fatigue Caused by Cancer

RATIONALE: Dextromethorphan may help relieve fatigue in patients with cancer. PURPOSE: This clinical trial is studying how well dextromethorphan works in treating patients with fatigue ca...

Dextromethorphan Pediatric Acute Cough Study

This is a placebo-controlled, double-blind, randomized, parallel group pilot study in approximately 150 subjects to evaluate the efficacy of dextromethorphan hydrobromide on acute cough in...

PubMed Articles [702 Associated PubMed Articles listed on BioPortfolio]

Kinetic investigation of dilute acid hydrolysis of hardwood pulp for microcrystalline cellulose production.

This work presents a kinetic investigation of dilute sulfuric acid hydrolysis of bleached hardwood kraft pulp. The temperature-time dependence shows fast xylose extraction during the initial period of...

Microcrystalline cellulose from Posidonia oceanica brown algae: Extraction and characterization.

Posidonia oceanica brown algae (POBA) represent an abundant and renewable biomass in Algerian seas. In the present study, the POBA were chemically treated through delignification and alkali treatment ...

Insights into the production and physicochemical properties of oxycellulose microcrystalline with coexisting crystalline forms.

Oxycellulose microcrystalline (Oxy-MCC) was prepared utilizing nonwood agro-industrial residue, rice husk (RH), via consecutive soda delignification and non-acidic catalytic oxidation. The resultant O...

Enhanced mechanical and hydrophobic properties of composite cassava starch films with stearic acid modified MCC (microcrystalline cellulose)/NCC (nanocellulose) as strength agent.

The green composite cassava starch films were prepared using stearic acid modified microcrystalline cellulose (M-MCC)/nanocellulose (M-NCC) as strength agent, which shows good mechanical and hydrophob...

Utilization of High throughput microcrystalline cellulose decorated silver nanoparticles as an eco-nematicide on root-knot nematodes.

The present study aimed to evaluate the influence of high throughput microcrystalline cellulose embedded silver nanoparticles (Ag-NPs), as an alternative eco-nematicide on Root-knot nematode (Meliodog...

Medical and Biotech [MESH] Definitions

A type of ion exchange chromatography using diethylaminoethyl cellulose (DEAE-CELLULOSE) as a positively charged resin. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)

Cellulose derivative used in chromatography, as ion-exchange material, and for various industrial applications.

A cellulose of varied carboxyl content retaining the fibrous structure. It is used as a local hemostatic and as a matrix for normal blood coagulation.

A family of glycosidases that hydrolyse crystalline CELLULOSE into soluble sugar molecules. Within this family there are a variety of enzyme subtypes with differing substrate specificities that must work together to bring about complete cellulose hydrolysis. They are found in structures called CELLULOSOMES.

An exocellulase with specificity for the hydrolysis of 1,4-beta-D-glucosidic linkages in CELLULOSE and cellotetraose. It catalyzes the hydrolysis of terminal non-reducing ends of beta-D-glucosides with release of CELLOBIOSE.

More From BioPortfolio on "Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion"

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...


Searches Linking to this Trial